Summary of COVID-19 ramipril studies

1. Huang et al., Ramipril for the Treatment of COVID-19: RAMIC, a Randomized, Double-Blind, Placebo-Controlled Clinical Trial

114 patient ramipril late treatment RCT: 144% higher mortality (p=1), 289% higher ventilation (p=1), 289% higher ICU admission (p=1), and 144% lower hospital discharge (p=1).
RCT 114 non-critically ill COVID-19 patients in the USA showing no significant differences with ramipril treatment.
Aug 2023, Advances in Therapy, https://link.springer.com/10.1007/s12325-023-02618-7, https://c19p.org/huang18